Pentobarbital desensitization in a 3-month-old child

Allergy and Asthma Proceedings

Volumn 25, Issue 4, 2004, Pages 225-228

  Butte, Manish J ^a,b   Dodson, Brenda ^a   Dioun, Anahita ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; CORTICOTROPIN; DOPAMINE; ISOFLURANE; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; TOPIRAMATE; VIGABATRIN;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DESENSITIZATION; DIAGNOSTIC PROCEDURE; GRAND MAL SEIZURE; HUMAN; HYPOTENSION; INFANT; INFANTILE SPASM; MALE; PAPULE; SKIN TEST; URTICARIA;

ANTICONVULSANTS; DESENSITIZATION, IMMUNOLOGIC; DRUG ERUPTIONS; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; MALE; PENTOBARBITAL; PHENOBARBITAL;

EID: 4544277045     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kim SJ, Lee DY, and Kim JS. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol 25:217-220, 2001.
2. Kofke WA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: A clinical series. Anesthesiology 71:653-659, 1989.
3. Taketomo CK, Hodding JH, and Kraus DM. Pediatric Dosage Handbook: Including Neonatal Dosing, Drug Administration, & Extemporaneous Preparations, 2000-2001, 7th ed. Hudson, OH: Lexi-Corp, Inc., 2000.
4. Turvey SE, Cronin B, Arnold AD, and Dioun AF. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol 92:426-432, 2004.
5. Froscher W, and Kleinhans D. Successful induction of tolerance in an epilepsy patient with phenobarbital allergy. Nervenarzt 69:158-161, 1998.
6. Klasco R. DRUGDEX System: Thomson MICROMEDEX, Greenwood Village, CO, 2004.
7. Kaur S, Sarkar R, Thami GP, and Kanwar AJ. Anticonvulsant hypersensitivity syndrome. Pediatr Dermatol 19:142-145, 2002.
8. Nashed MH, and Liao L. Possible atypical cross-sensitivity between phenytoin and carbamazepine in the anticonvulsant hypersensitivity syndrome. Pharmacotherapy 21:502-505, 2001.